Table 4.
Model 1 | Model 2 | |
---|---|---|
Cohort | ||
Spina Bifida | 5.67 (4.91, 6.56) | 5.12 (4.39, 5.97) |
Muscular Dystrophy | 4.25 (3.57, 5.07) | 3.70 (3.08, 4.44) |
Fragile X Syndrome. | 3.61 (2.34, 5.56) | 3.15 (2.02, 4.89) |
Comparison Group | Ref. | Ref. |
Gender | ||
Female | 1.06 (0.92, 1.21) | |
Male | Ref. | |
Age Group | ||
<20 years | Ref. | |
20–44 years | 0.82 (0.69, 0.96) | |
45–64 years | 0.90 (0.75, 1.09) | |
65 + years | 1.20 (0.96, 1.50) | |
Race/Ethnicity | ||
Non-Hispanic White | Ref. | |
Non-Hispanic Black | 1.24 (1.06, 1.45) | |
Hispanic/Other/Missing | 0.42 (0.32, 0.55) | |
Payer for Index Admission | ||
Commercial/Private | Ref. | |
Government | 1.18 (1.01, 1.37) | |
Self | 0.97 (0.74, 1.26) | |
Other/Unknown | 1.20 (0.90, 1.58) |
Bold indicates significance, p < 0.05.